Reviva Pharmaceuticals
RVPH
RVPH
22 hedge funds and large institutions have $5.76M invested in Reviva Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 9 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
56% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 9
Holders
22
Holding in Top 10
–
Calls
$1.27M
Puts
$821K
Top Buyers
| 1 | +$450K | |
| 2 | +$390K | |
| 3 | +$161K | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$122K |
| 5 |
Belvedere Trading
Chicago,
Illinois
|
+$26.6K |
Top Sellers
| 1 | -$249K | |
| 2 | -$164K | |
| 3 | -$128K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$77.2K |
| 5 |
Goldman Sachs
New York
|
-$71.2K |